IL41825A - Pyridine derivatives their preparation and pharmaceutical compositions containing them - Google Patents
Pyridine derivatives their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL41825A IL41825A IL41825A IL4182573A IL41825A IL 41825 A IL41825 A IL 41825A IL 41825 A IL41825 A IL 41825A IL 4182573 A IL4182573 A IL 4182573A IL 41825 A IL41825 A IL 41825A
- Authority
- IL
- Israel
- Prior art keywords
- group
- alk
- formula
- compound
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1528072A GB1437781A (en) | 1972-04-04 | 1972-04-04 | Pyridine derivatives having hypoglycaemic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL41825A0 IL41825A0 (en) | 1973-05-31 |
| IL41825A true IL41825A (en) | 1977-03-31 |
Family
ID=10056262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL41825A IL41825A (en) | 1972-04-04 | 1973-03-19 | Pyridine derivatives their preparation and pharmaceutical compositions containing them |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS49100091A (fr) |
| AR (1) | AR208269A1 (fr) |
| AT (1) | AT339301B (fr) |
| BE (1) | BE797715A (fr) |
| BG (1) | BG20352A3 (fr) |
| CA (1) | CA999868A (fr) |
| CH (1) | CH576961A5 (fr) |
| CS (1) | CS183689B2 (fr) |
| DD (1) | DD106834A5 (fr) |
| DE (1) | DE2316881A1 (fr) |
| ES (1) | ES413279A1 (fr) |
| FR (1) | FR2182933B1 (fr) |
| GB (1) | GB1437781A (fr) |
| HU (1) | HU165731B (fr) |
| IE (1) | IE37412B1 (fr) |
| IL (1) | IL41825A (fr) |
| NL (1) | NL7304610A (fr) |
| PL (1) | PL96043B1 (fr) |
| RO (2) | RO62274A (fr) |
| ZA (1) | ZA731853B (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409227A (en) | 1979-08-09 | 1983-10-11 | The Dow Chemical Co. | 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use |
| ES2077973T3 (es) * | 1991-07-03 | 1995-12-01 | Unilever Nv | Rellenos de chocolate con aditivo anti-eflorescente. |
| ATE121271T1 (de) * | 1991-07-03 | 1995-05-15 | Unilever Nv | Verbesserte schokolade-zusammensetzung. |
| US5453433A (en) * | 1994-05-13 | 1995-09-26 | Sterling Winthrop Inc. | Thiadiazoles and antipicornaviral compositions |
| US6043247A (en) * | 1996-04-19 | 2000-03-28 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
| AU2381497A (en) * | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| EP1056714B1 (fr) | 1998-02-26 | 2004-08-11 | Celltech Therapeutics Limited | Derives de phenylalanine en tant qu'inhibiteurs d'integrines alpha 4 |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| AU2001248553A1 (en) | 2000-04-17 | 2001-10-30 | Celltech R And D Limited | Enamine derivatives as cell adhesion molecules |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| US6740654B2 (en) | 2000-07-07 | 2004-05-25 | Celltech R & D Limited | Squaric acid derivatives |
| AU2001275724A1 (en) | 2000-08-02 | 2002-02-13 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
| US7101910B2 (en) * | 2001-06-12 | 2006-09-05 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| GB0405033D0 (en) * | 2004-03-05 | 2004-04-07 | Karobio Ab | Novel pharmaceutical compositions |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| EP3019034B1 (fr) * | 2013-07-01 | 2018-10-31 | Givaudan SA | Composés organiques |
| WO2016167153A1 (fr) * | 2015-04-15 | 2016-10-20 | 長谷川香料株式会社 | Modulateur d'arôme comprenant un dérivé de la pyridine ou un sel de celui-ci en tant que principe actif |
| EP3440052B1 (fr) * | 2016-04-06 | 2023-10-25 | University Of Oulu | Composés pour utilisation dans le traitement du cancer |
-
1972
- 1972-04-04 GB GB1528072A patent/GB1437781A/en not_active Expired
-
1973
- 1973-01-01 AR AR247376A patent/AR208269A1/es active
- 1973-03-15 IE IE426/73A patent/IE37412B1/xx unknown
- 1973-03-16 ZA ZA731853A patent/ZA731853B/xx unknown
- 1973-03-19 IL IL41825A patent/IL41825A/en unknown
- 1973-03-30 HU HURO717A patent/HU165731B/hu unknown
- 1973-04-02 AT AT286773A patent/AT339301B/de not_active IP Right Cessation
- 1973-04-03 ES ES413279A patent/ES413279A1/es not_active Expired
- 1973-04-03 JP JP48038610A patent/JPS49100091A/ja active Pending
- 1973-04-03 CS CS7300002387A patent/CS183689B2/cs unknown
- 1973-04-03 BE BE129595A patent/BE797715A/fr unknown
- 1973-04-03 NL NL7304610A patent/NL7304610A/xx not_active Application Discontinuation
- 1973-04-03 RO RO7300074369A patent/RO62274A/fr unknown
- 1973-04-03 CA CA167,818A patent/CA999868A/en not_active Expired
- 1973-04-03 RO RO7300083382A patent/RO63069A/fr unknown
- 1973-04-04 DD DD169942A patent/DD106834A5/xx unknown
- 1973-04-04 DE DE2316881A patent/DE2316881A1/de active Pending
- 1973-04-04 PL PL1973161704A patent/PL96043B1/pl unknown
- 1973-04-04 BG BG23170A patent/BG20352A3/xx unknown
- 1973-04-04 FR FR7312133A patent/FR2182933B1/fr not_active Expired
- 1973-04-04 CH CH482673A patent/CH576961A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2182933B1 (fr) | 1976-05-14 |
| AR208269A1 (es) | 1976-12-20 |
| ATA286773A (de) | 1977-02-15 |
| BE797715A (fr) | 1973-10-03 |
| IL41825A0 (en) | 1973-05-31 |
| CA999868A (en) | 1976-11-16 |
| CS183689B2 (en) | 1978-07-31 |
| DE2316881A1 (de) | 1973-10-11 |
| RO62274A (fr) | 1977-12-15 |
| AT339301B (de) | 1977-10-10 |
| ZA731853B (en) | 1974-01-30 |
| BG20352A3 (fr) | 1975-11-05 |
| JPS49100091A (fr) | 1974-09-20 |
| ES413279A1 (es) | 1976-01-01 |
| RO63069A (fr) | 1978-08-15 |
| IE37412L (en) | 1973-10-04 |
| HU165731B (fr) | 1974-10-28 |
| FR2182933A1 (fr) | 1973-12-14 |
| IE37412B1 (en) | 1977-07-20 |
| CH576961A5 (fr) | 1976-06-30 |
| PL96043B1 (pl) | 1977-11-30 |
| DD106834A5 (fr) | 1974-07-05 |
| NL7304610A (fr) | 1973-10-08 |
| GB1437781A (en) | 1976-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL41825A (en) | Pyridine derivatives their preparation and pharmaceutical compositions containing them | |
| US4036844A (en) | Aryloxypyridines | |
| US4053607A (en) | Aryloxypyridine for treating hyperglycaemia | |
| JP6033835B2 (ja) | カルシウム感知受容体モジュレーターとしてのベンゾ［ｂ］［１，４］オキサジン誘導体 | |
| JPS6089474A (ja) | モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤 | |
| CA1288102C (fr) | Derives de pyridine, leur preparation et leur emploi | |
| KR850000216B1 (ko) | 피페라진 유도체의 제조방법 | |
| JP2020520949A (ja) | 組成物、並びにミトコンドリア脱共役剤を調製及び使用する方法 | |
| IE912492A1 (en) | 1,4-disubstituted piperazines | |
| FI68396C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat | |
| JPH0717589B2 (ja) | 新規１，３―ジカルボニル化合物およびその組成物 | |
| US4727072A (en) | 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents | |
| DK168010B1 (da) | Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse | |
| SU1001856A3 (ru) | Способ получени фенилпиперазинпроизводных 1,3,4-оксадиазолилфенола или их кислотно-аддитивных солей | |
| KR100372312B1 (ko) | 신규의히드록시믹산유도체,그를포함한약제학적조성물및그의제조방법 | |
| IE55377B1 (en) | 1,5-diphenylpyrazolin-3-one compounds,method for preparing them,and pharmaceutical compositions containing these compounds | |
| CA2077122A1 (fr) | Derives de thio-uree, agent antimicrobien et agent anti-ulcereux a base de ces derives | |
| TW406074B (en) | Heterocyclyloxybenzoylguanidines | |
| JPH02115166A (ja) | ピリジルケトオキシムエーテル誘導体 | |
| US4758563A (en) | 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use | |
| JPS61212562A (ja) | 新規ピリジンメタノール誘導体及びそれを含有する医薬組成物 | |
| JPS62212386A (ja) | ２−ピリジルメチルベンズイミダゾ−ル誘導体 | |
| JPS62108863A (ja) | ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
| JPS61197576A (ja) | 新規なアリルアミン類 | |
| US4772704A (en) | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |